Dr. Katherine Emilie Rhoades Smith, MD

Dr. Smith practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Smith's NPI, 1316440126, was assigned on March 18, 2018. Dr. Smith graduated from Mercer University School of Medicine in 2018. Dr. Smith's Minnesota license number on file is 69315.

Dr. Smith's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Dr. Smith's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dr. Smith is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Smith to 1 more hospital, 1 clinical lab, 1 hospice and 1 medical group, each named with a free account. Dr. Smith's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smith practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Smith's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Smith is board certified in hematology by the American Board of Internal Medicine. Dr. Smith has a license on file in Minnesota.

Dmand AI lists breast cancer, chronic anemia, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Smith treats.

CMS data shows 155 Medicare services from Dr. Smith across 4 procedure codes in 2024, for 94 Medicare patients. Medicare paid $15,588 for them. Every service was in an office.

CMS counts 94 Medicare patients who saw Dr. Smith in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have cancer, and 71% have high blood pressure. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Smith's median patient age at 68, with 49% women.

In 2024, Dr. Smith wrote 261 Medicare Part D claims for 51 patients. 75% of them were for generic drugs. CMS names the drug for 110 of them, across 6 drugs with 11 or more claims each, at $7,363 in total drug cost. In 2023, CMS named 69 claims across 5 drugs.

Dr. Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Smith as offering telehealth.

Dmand AI links 10 papers to Dr. Smith, published from 2020 to 2025. 2021 was the busiest year, with 2. Dr. Smith's most frequent co-authors are Aaron S. Mansfield, MD, Mehmet Asim Bilen, MD and Svetomir N. Markovic, MD.

Dmand AI links Dr. Smith to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Neoplasm Metastasis and Neoplastic Processes. Open Payments lists research payments to Dr. Smith that name 1 trial.

CMS Open Payments shows 2 general payments to Dr. Smith from 1 drug or device company from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $114. It also lists 3 research payments totaling $201 in 2023, naming 1 clinical trial.

Dr. Smith graduated from Mercer University School of Medicine in 2018.

Dr. Smith is in network with 9 carriers, including Blue Cross Blue Shield of Michigan, Medica and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.